Guardian Pharmacy Services (NYSE: GRDN) furnishes updated investor presentation

Rhea-AI Filing Summary

Guardian Pharmacy Services, Inc. furnished an updated company presentation for use in meetings with investors, analysts, and other interested parties. The presentation, dated September 18, 2025, is provided as Exhibit 99.1 and is incorporated by reference into this report.

The company specifies that this investor presentation is being furnished rather than filed under securities laws, which limits how it is treated for certain legal purposes and how it may be incorporated into other securities law documents.

false 0001802255 0001802255 2025-09-18 2025-09-18

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 18, 2025

Guardian Pharmacy Services, Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-42284		87-3627139
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

300 Galleria Parkway SE
Suite 800
Atlanta, Georgia		30339
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (404) 810-0089

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Class A Common Stock, par value $0.001 per share		GRDN		New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

Guardian Pharmacy Services, Inc. (the “Company”) has prepared a presentation concerning its business that it intends to use in connection with meetings with investors, analysts, and other interested parties from time to time. A copy of the presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information set forth in this Item 7.01 (including Exhibit 99.1) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
99.1		Company Presentation, dated September 18, 2025.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

				Guardian Pharmacy Services, Inc.
September 18, 2025				By:		/s/ David K. Morris
				Name:		David K. Morris
				Title:		Executive Vice President and Chief Financial Officer

FAQ

What did Guardian Pharmacy Services, Inc. (GRDN) disclose in this 8-K?

Guardian Pharmacy Services, Inc. furnished a company presentation that it plans to use in meetings with investors, analysts, and other interested parties. The presentation is attached as Exhibit 99.1 and provides information about the company’s business.

How will Guardian Pharmacy Services, Inc. (GRDN) use the new investor presentation?

The company intends to use the investor presentation in meetings with investors, equity analysts, and other interested parties from time to time, offering a structured overview of its business and strategy.

Is the Guardian Pharmacy Services, Inc. (GRDN) investor presentation considered filed with the SEC?

No. The company states that the information in Item 7.01, including Exhibit 99.1, is being furnished and not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, unless specifically incorporated by reference elsewhere.

What exhibits are included with this Guardian Pharmacy Services, Inc. (GRDN) report?

The report includes a Company Presentation dated September 18, 2025 as Exhibit 99.1 and a Cover Page Interactive Data File as Exhibit 104 embedded within the Inline XBRL document.

Who signed this Guardian Pharmacy Services, Inc. (GRDN) report?

The report was signed on behalf of Guardian Pharmacy Services, Inc. by David K. Morris, who serves as Executive Vice President and Chief Financial Officer.

Does this Guardian Pharmacy Services, Inc. (GRDN) update include financial results or earnings data?

No specific financial results or earnings figures are described in the text of this report. The main item disclosed is the availability of an investor presentation as Exhibit 99.1.